Pharmaceutical companies increasing pressure to improve their performance in the face ongoing demand to deliver improved profitability and are under mounting pressure from payers, regulators, generics and an evolving mix of products. The traditional Sales & Marketing response –
driving revenue with ever larger sales forces - is no longer sustainable, particularly with an increased focus on ethical and regulatory compliance issues.
PwC has extensive experience of pharmaceutical sales and marketing and connects to over 8000 performance improvement and 2100 pharmaceutical specialists in 90 countries. We have recently published “Pharma 2020: The Vision, Which Path Will You Take?” using our expertise to stimulate discussion about the shape of Pharma in 2020.
The breadth of skills and experience within our global network gives us the ability to recognise, solve and exploit problems and opportunities faced by our pharmaceutical clients. The intellectual capital we bring allows us to challenge our clients and help solve their needs as they arise.
Our solution space is built on a broad capabilities drawing experience from across Pharma, healthcare and other industries. We have illustrated some of our capabilities with a few examples.
